Most Popular in:

Medical Esthetics Treatments

Email This Item! Print This Item!

Melanoma: The Negative Impact

By: Morag Currin
Posted: August 1, 2011, from the August 2011 issue of Skin Inc. magazine.
mole

page 6 of 7

Personality is associated with health status and the impact of cancer among melanoma survivors. In the field of medical psychology, the Type D personality has a distinct negative impact on health status in melanoma survivors and is an important factor to screen for in clinical practice. Individuals with this personality type have the tendency to experience increased negative emotions throughout time and situations, and tend not to share these emotions with others, because of fear of rejection or disapproval. Giving special attention to these clients is important, because they are more likely to experience a strong impact of cancer that cannot be explained by sociodemographical or clinical characteristics.

Once clients have finished treatment for melanoma, they may still be overwhelmed by emotions. This is the time for all melanoma patients to seek out emotional and social support. They need to find people who they can turn to for strength. Support can be found by caring skin care professionals who will put themselves out there to provide a place of solace and who are certified in esthetics for cancer patients and survivors. They will be assured that their chosen therapist can provide them with a safe and beneficial treatment.

Rewarding work

Any skin care professional who recognizes any form of skin cancer in clients will be emotionally and psychologically rewarded for making the difference in—and possibly saving—the life of a client.

GENERAL REFERENCES

F Mols, C Holterhues, T Nijsten and LV van de Poll-Franse, Personality is associated with health status and impact of cancer among melanoma survivors, Eur J Cancer 46 3 573–580 (Feb 2010)

International Agency for Research on Cancer Working Group, The association of use of sunbeds with cutaneous malignant melanoma and other skin cancers: A systematic review, Int J Cancer 120 11 2526 (Jun 2007)